The field includes research findings that are discovered during the genetic tests in laboratories. These tests are mostly concerned with the findings of genetic research. The past decade has seen a transition towards new testing technologies that focus on the genome as a whole, driven by affordable sequencing technologies. As costs of exome or genome sequencing rapidly approach the cost of a single gene test, personalized medicine applications become more feasible. However, the use of whole genome or exome sequencing carries a risk of creating incidental findings (IF). A number of ethical, legal and clinically practical issues are raised by incidental findings, defined as “a finding concerning an individual research participant that has potential health or reproductive importance and is discovered in the course of conducting research but is beyond the aims of the study”.